MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 82989-25-1
Formula C13H15N5O3MW 289.29Research-use catalog entryCOA/SDS by request

Butyl 2-oxo-2-((3-(2H-tetrazol-5-yl)phenyl)amino)acetate

CAS Number: 82989-25-1

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
1 mg
Purity
98+%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 mg
Purity
98+%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: XQTARQNQIVVBRX-UHFFFAOYSA-NC13H15N5O3 | MW 289.29

Chemical Absolute Identifiers

CAS Number

82989-25-1

PubChem CID

5380

Molecular Formula

C13H15N5O3

Molecular Weight

289.29 g/mol

Exact Mass

289.117489

InChIKey

XQTARQNQIVVBRX-UHFFFAOYSA-N

IUPAC Name

butyl 2-oxo-2-[3-(2H-tetrazol-5-yl)anilino]acetate

SMILES String

CCCCOC(=O)C(=O)NC1=CC=CC(=C1)C2=NNN=N2

Physical Properties

No physical property values available.

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Butyl 2-oxo-2-((3-(2H-tetrazol-5-yl)phenyl)amino)acetate (CAS 82989-25-1) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C13H15N5O3 and molecular weight 289. 29 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Pharmaceutical Intermediate ResearchResearch intermediateCustom synthesis building blockPharmaceutical intermediate researchResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Nuclear receptor subfamily 1 group I member 2 (Homo sapiens) — 3 assays; 5-hydroxytryptamine receptor 2A (Homo sapiens) — 2 assays; 5-hydroxytryptamine receptor 2B (Homo sapiens) — 2 assays; Alpha-1A adrenergic receptor (Homo sapiens) — 2 assays; Alpha-2A adrenergic receptor (Homo sapiens) — 2 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Nuclear receptor subfamily 1 group I member 2

Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

5-hydroxytryptamine receptor 2A

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

5-hydroxytryptamine receptor 2B

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Alpha-1A adrenergic receptor

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Alpha-2A adrenergic receptor

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Safety & Handling

PPE

Respiratory protection if needed

First Aid

  • Do not give anything to an unconscious person.
  • Rinse mouth with water.

Stability / Reactivity

  • and reactivity.

Disposal

  • Dispose of remaining and non-recyclable solutions to a licensed company.
  • Contact a professional organization with a waste disposal license to handle this substance.
Show additional safety reference fields

Accidental Release

  • Use personal protective equipment.
  • Avoid dust generation.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Butyl 2-oxo-2-((3-(2H-tetrazol-5-yl)phenyl)amino)acetate

Names & Synonyms

tazanolastTazanolTazanolastumButyl 3'-(1H-tetrazol-5-yl)oxanilatebutyl-3'-(1H-tetrazol-5-yl)oxanilate
Show all synonyms
Butyl 2-((3-(1H-tetrazol-5-yl)phenyl)amino)-2-oxoacetate5-(3-n-Butyloxalylaminophenyl)tetrazoleTazalestTazanolast [INN:JAN]Tazanolastum [INN-Latin]Tazanol (TN)TAZANOLAST [MI]Oxo((3-(1H-tetrazol-5-yl)phenyl)amino)acetic acid butyl esterTazanolast (JAN/INN)TAZANOLAST [INN]TAZANOLAST [JAN]TAZANOLAST [WHO-DD]Acetic acid, oxo((3-(1H-tetrazol-5-yl)phenyl)amino)-, butyl esterButyl oxo[3-(1H-tetrazol-5-yl)anilino]acetate
External Identifiers
DSSTOX SUBSTANCE ID: DTXSID6048626CHEMBL ID: CHEMBL564109CHEBI ID: CHEBI:32183UNII: T0248823H1DRUGBANK ID: DB21203KEGG ID: D01669NCI THESAURUS CODE: C76764WIKIDATA ID: Q27289492
Literature & Patent References
DOI 10.1038/s41467-023-40064-9A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.PMID 37468498A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.DOI 10.1016/j.ejmech.2008.12.004Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.PMID 19128860Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Additional text reference cues are not available for this catalog entry.

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 106516-24-9SertindoleCAS 107724-20-9EplerenoneCAS 114-07-8ErythromycinCAS 100643-71-8DesloratadineCAS 102767-28-2LevetiracetamCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acidCAS 1018128-07-8Isopropyl 4-chloro-2-methylquinoline-6-carboxylateCAS 1018142-22-76-cyclopropyl-1-(2,2-difluoroethyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid

RFQ questions for CAS 82989-25-1

What are the key identifiers for Butyl 2-oxo-2-((3-(2H-tetrazol-5-yl)phenyl)amino)acetate (CAS 82989-25-1)?

Butyl 2-oxo-2-((3-(2H-tetrazol-5-yl)phenyl)amino)acetate is identified by CAS 82989-25-1, with molecular formula C13H15N5O3, molecular weight 289.29, InChIKey XQTARQNQIVVBRX-UHFFFAOYSA-N.

Does CAS 82989-25-1 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Nuclear receptor subfamily 1 group I member 2, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, Alpha-1A adrenergic receptor, Alpha-2A adrenergic receptor. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 82989-25-1?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Butyl 2-oxo-2-((3-(2H-tetrazol-5-yl)phenyl)amino)acetate?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 82989-25-1 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.